Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., listed under the ticker PWUP, is a biopharmaceutical-focused company that emerged from a SPAC business combination targeting the life sciences and healthcare sector. The company filed an 8-K with the SEC on February 21, 2025, under accession number 0001493152-25-007898, reflecting a current corporate disclosure event. PWUP operated as a blank check acquisition vehicle prior to its combination, with its post-merger entity carrying forward the Aspire Biopharma Holdings name. The filing marks an active reporting status on public markets within the biopharma space. Sign up for full data, filings history, and deal analytics on SpacDesk at spacdesk.com.